Beth Seidenberg

Beth Seidenberg

Direktör/Styrelseledamot på KYVERNA THERAPEUTICS, INC.

Förmögenhet: 6 M $ per 2026-08-31

69 år
Health Technology
Technology Services
Finance

Profil

Dr. Beth C.
Seidenberg
, MD, is an Independent Director at Latigo Biotherapeutics, Inc., a Founding Managing Director at Westlake Biopartners LLC, an Independent Director at Kyverna Therapeutics, Inc., an Independent Director at Vera Therapeutics, Inc., a Lead Independent Director at Sagimet Biosciences, Inc. and a Chairman at Kate Therapeutics, Inc. She is on the Board of Directors at Latigo Biotherapeutics, Inc., Electra Therapeutics, Inc., Kyverna Therapeutics, Inc., Expansion Therapeutics, Inc., Vera Therapeutics, Inc., Sagimet Biosciences, Inc., Arsenal Biosciences, Inc., Auxogyn, Inc., Breathe Technologies, Inc., Cell Design Labs, Inc., Jamanda Ltd., Mango Health, Inc., Spruce Health, Inc., Star OpCo, Inc. and Tmunity Therapeutics, Inc. Dr. Seidenberg was previously employed as an Independent Director by ACELYRIN, Inc., an Independent Director by Atara Biotherapeutics, Inc., a Lead Independent Director by Progyny, Inc., an Independent Director by Epizyme, Inc., an Advisor by Kleiner Perkins Caufield & Byers LLC, a Chief Medical Officer & Senior Vice President by Amgen, Inc., a Senior Vice President-Global Development by Bristol Myers Squibb Co., a Senior Executive-Research & Development by Merck & Co., Inc., a VP-Immunology, Pulmonary & Dermatology by Merck Research Laboratories Massachusetts LLC, a Chairman by Arresto BioSciences, Inc., a Chairman by Flexus Biosciences, Inc., and a Researcher by National Institutes of Health.
She also served on the board at Rapt Therapeutics, Inc., Practice Fusion, Inc., ARMO Biosciences, Inc., Tesaro, Inc., BioCryst Pharmaceuticals, Inc., iPierian, Inc., Livongo Health, Inc., RedBrick Health Corp.
and True North Therapeutics, Inc. She received her undergraduate degree from Barnard College and a doctorate degree from The University of Miami Leonard M.
Miller School of Medicine.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-05-21 135 565 ( 0,19 % ) 5 M $ 2026-08-31
2026-06-12 131 643 ( 0,22 % ) 1 M $ 2026-08-31
2026-05-27 21 727 ( 0,04 % ) 184 136 $ 2026-08-31

Aktiva positioner av Beth Seidenberg

FöretagPositionStart
SAGIMET BIOSCIENCES INC. Direktör/Styrelseledamot 2007-04-01
KYVERNA THERAPEUTICS, INC. Direktör/Styrelseledamot 2018-09-01
VERA THERAPEUTICS, INC. Direktör/Styrelseledamot 2016-06-01
ELECTRA THERAPEUTICS, INC. Direktör/Styrelseledamot 2019-03-01
LATIGO BIOTHERAPEUTICS, INC. Direktör/Styrelseledamot 2024-07-01
Direktör/Styrelseledamot 2018-01-03
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Grundare 2018-09-01
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ -
░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -

Tidigare kända positioner av Beth Seidenberg

FöretagPositionSlut
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Beth Seidenbergs erfarenhet

Beth Seidenbergs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

70

Första gradens relationer

40

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag40

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Government

Consumer Services

Health Technology

Technology Services

Commercial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Technology Services

Health Technology

Technology Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Beth Seidenberg